US: Trump’s funding cuts jeopardize fentanyl overdose prevention and recovery

Americans from all walks of life are deeply concerned about addiction, overdose, and the impact of fentanyl. Families across the U.S.—whether from cities, suburbs, or rural communities— desperately want to protect their loved ones and keep them alive.

When it comes to solutions, Americans broadly agree that access to treatment, the opioid/fentanyl reversal medication naloxone, and other health services are critical for saving lives and offering a path to recovery.

Yet, the Trump Administration’s and Congress’s proposed federal funding cuts pose an immediate and catastrophic threat to these vital services. By slashing Medicaid and public health grant programs, Trump’s cuts will directly hinder access to treatment, naloxone, and vital health services. The results could be devastating: more lives lost to overdose, increased suffering, and addiction spiraling out of control. We cannot let these cuts go through—every second counts.

Kassandra Frederique, Executive Director of the Drug Policy Alliance, answers urgent questions to help us understand the immense threat posed by Trump’s federal funding cuts and what can be done to protect our loved ones and ourselves.